Analytical Data
-
基因名
T114M
- Application
-
别名
/
-
种属
Human
-
表达系统
Baculovirus
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P00747
-
表达区间
20-810aa(R386Q)
-
分子量
92.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
T114M is a variant of a recombinant protein that has garnered significant attention in the fields of molecular biology and protein engineering. The research surrounding T114M primarily focuses on its potential applications in therapeutic development, particularly in the context of enzyme replacement therapies and targeted treatment strategies for genetic disorders. The mutation, characterized by a threonine to methionine substitution at position 114, may influence the protein's stability, activity, or interaction with other biomolecules. Studies have demonstrated that understanding such mutations can provide insights into protein functionality and aid in the design of more effective treatments for conditions where enzyme deficiencies play a critical role. Additionally, the exploration of T114M can facilitate advancements in biotechnological applications, including the development of novel biocatalysts and diagnostic tools. The ongoing research aims to elucidate the structural and functional implications of this variant, potentially leading to innovative solutions in both therapeutic and industrial contexts. Overall, T114M serves as a valuable model for understanding the complexities of protein variations and their impact on biological processes.
